{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T07:00:32Z","timestamp":1777705232825,"version":"3.51.4"},"reference-count":69,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Pulmonology"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This review is the second article in the State\u2010of\u2010the\u2010Art series and aims to evaluate medications used in the treatment of allergic bronchopulmonary aspergillosis (ABPA) in pediatric and adult patients with cystic fibrosis (CF). ABPA is one of several organisms that are found in the airways of CF patients. This review provides an evidence\u2010based summary of pharmacokinetic (PK)\/pharmacodynamic (PD), tolerability, and efficacy studies of medications including corticosteroids, amphotericin B, azole antifungals (isavuconazole, itraconazole, posaconazole, and voriconazole), and a monoclonal antibody omalizumab in the treatment of ABPA and identifies areas where further study is warranted.<\/jats:p>","DOI":"10.1002\/ppul.25080","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T14:29:07Z","timestamp":1600439347000},"page":"3541-3572","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations:\u202f II. Therapies for allergic bronchopulmonary aspergillosis"],"prefix":"10.1002","volume":"55","author":[{"given":"Quovadis J.","family":"Epps","sequence":"first","affiliation":[{"name":"Florida Agricultural and Mechanical University College of Pharmacy and Pharmaceutical Sciences Florida Agricultural and Mechanical University Jacksonville Florida USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin L.","family":"Epps","sequence":"additional","affiliation":[{"name":"Department of Pharmacy The Mayo Clinic Jacksonville Florida USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6047-306X","authenticated-orcid":false,"given":"Jeffery T.","family":"Zobell","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Intermountain Primary Children's Hospital Salt Lake City Utah USA"},{"name":"Intermountain Healthcare Primary Children's Cystic Fibrosis Pediatric Center Salt Lake City Utah USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0977-7257","authenticated-orcid":false,"given":"David C.","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice L.S. Skaggs Pharmacy Institute, University of Utah College of Pharmacy Salt Lake City Utah USA"},{"name":"University of Utah University of Utah Adult Cystic Fibrosis Center Salt Lake City Utah USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607183350307"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201405-203AS"},{"key":"e_1_2_8_4_1","first-page":"Cd002204","article-title":"Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis","volume":"11","author":"Elphick HE","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2004.11.018"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21240"},{"issue":"2","key":"e_1_2_8_7_1","first-page":"203","article-title":"Steroids: pharmacology, complications, and practice delivery issues","volume":"14","author":"Ericson\u2010Neilsen W","year":"2014","journal-title":"Ochsner J"},{"key":"e_1_2_8_8_1","unstructured":"Solu\u2010Medrol(R) approved package labeling. Pharmacia & Upjohn Co. Sept2020."},{"key":"e_1_2_8_9_1","unstructured":"Ampohtericin B for injection approved package labeling. XGen Pharmaceuticals. April2010."},{"key":"e_1_2_8_10_1","unstructured":"Abelect(R) approved package labeling. Sigma\u2010Tau Pharmasource Inc.March2013."},{"key":"e_1_2_8_11_1","unstructured":"Ambisome(R) approved package labeling. Astellas Pharma US Inc. July2020."},{"key":"e_1_2_8_12_1","unstructured":"Cresemba(R) approved package labeling. Astellas Pharma Inc. Dec2019."},{"key":"e_1_2_8_13_1","unstructured":"Sporanox(R) approved package labeling. Pricara Division of Ortho\u2010McNeil\u2010Janssen Pharmaceuticals Inc. 2001."},{"key":"e_1_2_8_14_1","unstructured":"Noxafil(R) approved package labeling. Merck Inc. Nov2015."},{"key":"e_1_2_8_15_1","unstructured":"Vfend(R) approved package labeling. Pfizer Inc. Sept 2020."},{"key":"e_1_2_8_16_1","unstructured":"Xolair(R) approved package labeling. Genentech Inc. May2019."},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12878"},{"key":"e_1_2_8_18_1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/tid.12712","article-title":"Use of isavuconazole in a patient with voriconazole\u2010induced QTc prolongation","volume":"19","author":"Trang TP","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2019-0192"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.6.1937-1938.2001"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh175"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200645110-00004"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31819de6fd"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myz015"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr300"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2012.09.007"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2011.12.006"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2009.00384.x"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00504-10"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000371"},{"issue":"5","key":"e_1_2_8_31_1","doi-asserted-by":"crossref","first-page":"e1259","DOI":"10.1542\/peds.2009-2042","article-title":"Bolus methylprednisolone efficacy for uncontrolled exacerbation of cystic fibrosis in children","volume":"125","author":"Ghdifan S","year":"2010","journal-title":"Pediatrics"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2009.04.008"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20333"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-0843"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.105.1.32"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(02)00425-4"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00146707"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/376287"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21300"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1179\/1973947814Y.0000000194"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.100.3.813"},{"issue":"4","key":"e_1_2_8_42_1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1378\/chest.103.4.1311a","article-title":"Ventilation\u2010perfusion inequalities in a patient with obliterative bronchiolitis after single\u2010lung transplantation for primary pulmonary hypertension","volume":"103","author":"Mannes GPM","year":"1993","journal-title":"Chest"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2736(99)00038-3"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2002.23583.x"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036077"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05077-11"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0896(01)00349-2"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(03)00022-5"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2002.tb02894.x"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2012.10.007"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz075"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1086\/343743"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2005.05.019"},{"issue":"1","key":"e_1_2_8_54_1","first-page":"29","article-title":"Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis","volume":"102","author":"Glackin L","year":"2009","journal-title":"Ir Med J"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2019.02.001"},{"issue":"3","key":"e_1_2_8_56_1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1183\/09031936.00097611","article-title":"High frequency of voriconazole\u2010related phototoxicity in cystic fibrosis patients","volume":"39","author":"Rondeau S","year":"2012","journal-title":"Eur Respir J"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20907"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1177\/1753465814547517"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028015624204"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23612"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.01.056"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2017.11.007"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.22937"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2012.11.004"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20804"},{"issue":"13","key":"e_1_2_8_66_1","first-page":"1839","article-title":"Anti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis","volume":"18","author":"Zicari AM","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-17.1.88"},{"key":"e_1_2_8_68_1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/JAA.S156049","article-title":"Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis","volume":"11","author":"Ashkenazi M","year":"2018","journal-title":"J Asthma Allergy"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-5890(01)00087-6"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1086\/376525"}],"container-title":["Pediatric Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ppul.25080","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ppul.25080","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ppul.25080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T09:33:35Z","timestamp":1693733615000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ppul.25080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":69,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1002\/ppul.25080"],"URL":"https:\/\/doi.org\/10.1002\/ppul.25080","archive":["Portico"],"relation":{},"ISSN":["8755-6863","1099-0496"],"issn-type":[{"value":"8755-6863","type":"print"},{"value":"1099-0496","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"assertion":[{"value":"2020-06-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}